Journal of the Korean Magnetic Resonance Society (한국자기공명학회논문지)

Korean Magnetic Resonance Society (한국자기공명학회)
권호 표지
DOI QR코드

DOI QR Code

Optimized purification and characterization of expressed hMC4R-TM2

  • Park, Yu-Geun (Department of Chemistry, Protein Research Center for Bio-Industry, Hankuk University of Foreign Studies) ;
  • Song, Jooyoung (Department of Chemistry, Protein Research Center for Bio-Industry, Hankuk University of Foreign Studies) ;
  • Kim, Yongae (Department of Chemistry, Protein Research Center for Bio-Industry, Hankuk University of Foreign Studies)
  • Received : 2012.11.15
  • Accepted : 2012.12.10
  • Published : 2012.12.20
Download PDF
⟨ Previous Next ⟩

Abstract

Human melanocortin-4 receptor (hMC4R) among MC-Rs, expressed in the brain, is in charge of the control on energy homeostasis and food intake. The structure and function of human MC4R have been studied to understand their essential function and roles. To investigate the structure and function, it is necessary to prepare sufficient amounts of proteins. However, their expression and purification is demanding and time-consuming due to their innate insoluble and toxic properties. The heterozygous mutations of hMC4R, exchange of Asp 90 to Asn located in second transmembrane, cause severe obesity in human. To obtain purified hMC4R wt-TM2 for structural studies, it was first over-expressed and purified by fast protein liquid chromatography (FPLC) and then solution NMR studies were performed to get high-resolution spectra. In here, we established optimized purification scheme to get more purified target peptide.

Keywords

References

  1. P. Prusis, P. A. Frandberg, R. Muceniece, I. Kalvinsh, J. E. S. Wikberg, Biochem. Biophy. Res. Com. 210, 205 (1995). https://doi.org/10.1006/bbrc.1995.1647
  2. N. M. Brito, A. N. Brito, D. J. Baro, C. K. Song, and T. J. Bartness, Endocrinology. 11, 5339 (2007).
  3. H Wessells1, N Levine1, ME Hadley, R Dorr, V Hruby, Int. J. Imp. Res. 12, S74 (2000). https://doi.org/10.1038/sj.ijir.3900582
  4. Y.-X. Tao, Mol, Cell, Endo 239, 1 (2005). https://doi.org/10.1016/j.mce.2005.04.012
  5. Y. Yang, J. Pharm, 660, 125 (2011).
  6. K.-S. Kima, J.M. Reecy, W.H. Hsu, L.L. Anderson, M.F. Rothschild, Dom. Ani. Endo, 26. 75 (2004). https://doi.org/10.1016/j.domaniend.2003.12.001
  7. D. L. Marks, V. Hruby, G. Brookhart, R. D. Cone, Peptides, 27, 259 (2006). https://doi.org/10.1016/j.peptides.2005.01.025
  8. C. Vaisse, K. Clement, E. Durand, S. Hercberg, B. Guy-Grand, P. Froguel, J. Clin. Invest. 106, 253 (2000). https://doi.org/10.1172/JCI9238
  9. van der Kraan M . Endocrinology 139, 2348 (1998). https://doi.org/10.1210/en.139.5.2348
  10. K.G.Mountjoy, L.S. Robbins, M.T. Mortrud, R.D.Cone Science. 257, 1248 (1992). https://doi.org/10.1126/science.1325670
  11. V .Chhajlani, J.E.S.Wikberg. FEBS Lett. 309, 417 (1992). https://doi.org/10.1016/0014-5793(92)80820-7
  12. I . Gantz et, J Biol Chem. 268, 8246 (1993).
  13. T.J. Park, S.S. Choi, A.A. Gang, Y. Kim, Prot. Exp. Puri. 62, 139 (2008). https://doi.org/10.1016/j.pep.2008.08.008
  14. C. Diefenderfer, J. Lee, S. Mlyanarski, Y. G., Kerney J. Glover Analytical Biochemistry 384, 274 (2009). https://doi.org/10.1016/j.ab.2008.09.038